Skip to content
Annual Report summary 2022-2023 20th February 2024 Annual Report 2022-2023 13th December 2023

The IVCC Annual Report 2022-2023 has been published.

The report showcases IVCC’s work to facilitate innovative approaches to preventing vector-borne diseases and tackle the growing threat of insecticide resistance. With activities across the globe and spanning research and development and market access, we are accelerating the process from innovation to impact.

The report is a reminder of the importance of collaborative working and the progress laid out in it is testament, too, to the commitment of our partners from industry, academia, the public sector, and advocacy. We are grateful for the support of all our funders, who make life-saving vector control possible.

Earlier in 2023 IVCC embarked upon a strategic review to assess and realign priorities to ensure that we are focusing on the unmet needs that will have the most significant impact against vector-borne disease. The annual report outlines IVCC’s strategic priorities going forward.

Another highlight is a section on climate change and the dramatic impact it is having on vector-borne disease transmission, demanding new policies, tools and approaches.

“At this pivotal time for global health, I call upon the wider global community to ensure that, as IVCC and its partnerships continue with their missions, appropriate political will and funding, facilitates and strengthens our collective efforts to eradicate malaria and the neglected tropical diseases that afflict the most vulnerable members of society.”

Sherwin Charles, Chair, Board of Trustees, IVCC.

For more information or to request a physical copy please provide your full name and postal address to Laura Roberts on laura.roberts@ivcc.com.

Chief Executive Officer Nick Hamon announces retirement 24th June 2022

After 9 years as IVCC’s Chief Executive Officer, Nick Hamon has decided to retire. Nick will step down from his role once the IVCC Board of Trustees has completed its search for Nick’s successor and an appropriate transition period, if required, is completed.

Under Nick’s guidance and leadership, IVCC has grown from a small team of seven with grant income of $10m from a single funder to a full-service Product Development Partnership (PDP) supported by eight key funders and over 30 full-time staff, covering product development and market shaping projects across sub-Saharan Africa and the Indo-Pacific region, securing over $300 million of grant income to further vector control innovation.

Nick Hamon said: “It has been an honour and a privilege to lead IVCC for the last nine years.  Together with the support of our funding and industry partners, IVCC continues to deliver a portfolio of innovative vector control tools and marketing shaping interventions, which has enabled lifesaving products to be delivered at pace and scale to those that need them most.”

“I would like to thank all of my colleagues at IVCC and our partners and other stakeholders across vector control who have helped IVCC play such a pivotal role in the global battle to eradicate malaria.”

Commenting on his retirement, Board of Trustees Chair, Sir Stephen O’Brien said: “Given Nick’s decision to move to his well-earned retirement, the IVCC Board is very grateful that he has agreed to remain fully at the helm of IVCC until his successor is in place, the global search for whom the IVCC Board is now actively pursuing.”

“There will soon come the right moment to recognise and celebrate Nick’s considerable achievements in full; for now, I highlight that through Nick’s leadership IVCC has become established as a world-leading PDP.  I and all my colleagues on the Board and the IVCC team are immensely grateful to Nick for his skill and relentless commitment to IVCC and all it stands for. On behalf of the whole malaria community, I would like to express my sincere thanks for his leadership of IVCC, which has significantly contributed towards saving thousands of lives, something which, modest as he is, Nick should justifiably be extremely proud of.”

IVCC’s Annual Report 2022-2023 13th December 2023

The IVCC Annual Report 2022-2023 has been published.

The report showcases IVCC’s work to facilitate innovative approaches to preventing vector-borne diseases and tackle the growing threat of insecticide resistance. With activities across the globe and spanning research and development and market access, we are accelerating the process from innovation to impact.

The report is a reminder of the importance of collaborative working and the progress laid out in it is testament, too, to the commitment of our partners from industry, academia, the public sector, and advocacy. We are grateful for the support of all our funders, who make life-saving vector control possible.

Earlier in 2023 IVCC embarked upon a strategic review to assess and realign priorities to ensure that we are focusing on the unmet needs that will have the most significant impact against vector-borne disease. The annual report outlines IVCC’s strategic priorities going forward.

Another highlight is a section on climate change and the dramatic impact it is having on vector-borne disease transmission, demanding new policies, tools and approaches.

“At this pivotal time for global health, I call upon the wider global community to ensure that, as IVCC and its partnerships continue with their missions, appropriate political will and funding, facilitates and strengthens our collective efforts to eradicate malaria and the neglected tropical diseases that afflict the most vulnerable members of society.”

Sherwin Charles, Chair, Board of Trustees, IVCC.

For more information or to request a physical copy please provide your full name and postal address to Laura Roberts on laura.roberts@ivcc.com.

Sign up to receive the IVCC Newsletter